SYRS
Syros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Leverage
- Debt / equity
- -5.41x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.71x
- Debt / EBITDA
- -0.66x
- Net debt / EBITDA
- -0.02x
Liquidity & coverage
- Current ratio
- 2.25x
- Quick ratio
- 2.25x
- Cash ratio
- 2.05x
- Interest coverage
- -20.92x
- EBITDA / interest
- -17.11x
- Working capital
- $35.5M
Cash & dividend
- FCF / debt
- -1.66x
- Cash flow / debt
- -1.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2024